FASEB Journal: Official Publication Federation Am Soc Experimental Biology
Following FDA-approved administration guidelines minimizes the risk of intramuscular injection and other complications
Although these drugs do work and should be used for the right reason, we just want to caution everyone that if you do decide to start this, be prepared that you have a 30 percent chance that you may have GI side effects, and then the drug may have to be discontinued, said study author Dr
Most NAION cases reported in clinical studies occurred within the first year of semaglutide use, suggesting a drug-induced effect related to treatment initiation or rapid metabolic changes
The most appropriate treatment depends on factors including: medical history BMI weight-related health risks previous treatment response current medication personal preferences potential side effects clinical eligibility Semaglutide is injected under the skin rather than into a muscle or vein
Global Burden Disease Collaborators